Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about Gic Leads $85M Series B Round In Chinese Biotech Firm Harbour Biomed – China Money Network
Venture Capital

Gic Leads $85M Series B Round In Chinese Biotech Firm Harbour Biomed – China Money Network

by chinamoneynetwork.com posted 11months ago 70 views
Shanghai-based biopharmaceutical company Harbour BioMed today announced that it had raised US$85 million series B round led by Government of Singapore Investment Corp (GIC).New investors including China Life Investment and Vertex Ventures, as well as existing investors Advantech Capital and Legend Capital also participated in this round. Harbour BioMed was established in December 2016 around a series A round of $50 million and the acquisition of the Netherlands-based fully human transgenic antibody technology company, Harbour Antibodies BV and its subsidiaries.